Cargando...
Progress toward Gene Therapy for Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) has been a major target for gene therapy development for nearly 30 years. DMD is among the most common genetic diseases, and isolation of the defective gene (DMD, or dystrophin) was a landmark discovery, as it was the first time a human disease gene had been cloned...
Gardado en:
| Publicado en: | Mol Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Gene & Cell Therapy
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417844/ https://ncbi.nlm.nih.gov/pubmed/28416280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.02.019 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|